Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Ma

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Viruses|April 27, 2026
Induction Cisplatin, Docetaxel, and 5-Fluorouracil Versus Platinum Doublet in Human Papillomavirus-Associated Oropharyngeal CancerAshwin Ganti, Patrick W McGarrah, Harry Fuentes Bayne, et al.
Oral Oncology|November 2, 2025
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patientsAgnes Q Zhu, Claire E Cassianni, Travis Haller, et al.
Oral Oncology|January 11, 2024
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancerAisha A Aden, Felicia O Olawuni, Chadi N Abdel-Halim, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2017
Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional ReviewDavid M Routman, Ryan K Funk, Kanograt Tangsriwong, et al.
Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.
Advances in Radiation Oncology|May 8, 2023
Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter ExperienceBrady S Laughlin, Sasha Ebrahimi, Molly M Voss, et al.
Practical Radiation Oncology|January 31, 2016
Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice reviewCharles S Mayo, Thomas M Pisansky, Ivy A Petersen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancerGohar S Manzar, Scott C Lester, David M Routman, et al.
Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.
Molecular Cancer Therapeutics|July 5, 2018
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain BarrierMinjee Kim, Daniel J Ma, David Calligaris, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Viruses|April 27, 2026
Induction Cisplatin, Docetaxel, and 5-Fluorouracil Versus Platinum Doublet in Human Papillomavirus-Associated Oropharyngeal CancerAshwin Ganti, Patrick W McGarrah, Harry Fuentes Bayne, et al.
Oral Oncology|November 2, 2025
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patientsAgnes Q Zhu, Claire E Cassianni, Travis Haller, et al.
Oral Oncology|January 11, 2024
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancerAisha A Aden, Felicia O Olawuni, Chadi N Abdel-Halim, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2017
Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional ReviewDavid M Routman, Ryan K Funk, Kanograt Tangsriwong, et al.
Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.
Advances in Radiation Oncology|May 8, 2023
Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter ExperienceBrady S Laughlin, Sasha Ebrahimi, Molly M Voss, et al.
Practical Radiation Oncology|January 31, 2016
Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice reviewCharles S Mayo, Thomas M Pisansky, Ivy A Petersen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancerGohar S Manzar, Scott C Lester, David M Routman, et al.
Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.
Molecular Cancer Therapeutics|July 5, 2018
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain BarrierMinjee Kim, Daniel J Ma, David Calligaris, et al.
Pageof 11